Qube Research & Technologies (QRT)’s Pliant Therapeutics PLRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4K	Sell	10,033 -933	-9%	-$1.14K	﹤0.01%	3274
2026 Q1	$13.8K	Sell	10,966 -4,459	-29%	-$5.63K	﹤0.01%	3308
2025 Q4	$18.8K	Sell	15,425 -34,090	-69%	-$51.2K	﹤0.01%	3390
2025 Q3	$73.3K	Sell	49,515 -102,147	-67%	-$156K	﹤0.01%	3117
2025 Q2	$176K	Buy	+151,662	New	+$214K	﹤0.01%	2935
2023 Q3	–	Sell	-74,025	Closed	-$1.34M	–	4280
2023 Q2	$1.34M	Sell	74,025 -101,850	-58%	-$2.41M	﹤0.01%	1188
2023 Q1	$4.68M	Buy	175,875 +98,805	+128%	+$2.81M	0.02%	695
2022 Q4	$1.49M	Buy	77,070 +50,169	+186%	+$1.05M	0.01%	1051
2022 Q3	$562K	Buy	26,901 +13,442	+100%	+$257K	﹤0.01%	1426
2022 Q2	$108K	Buy	+13,459	New	+$86.2K	﹤0.01%	1921

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PLRX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Pliant Therapeutics (PLRX) stake by 8.5% in Q2 2026, selling an estimated $1.14K and leaving 10,033 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3274.

Qube Research & Technologies (QRT) first reported a position in PLRX in Q2 2022 and has held it in 10 quarters since. The position peaked at $4.68M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Qube Research & Technologies (QRT) held 10,033 shares of Pliant Therapeutics worth $11.4K as of Q2 2026.
Qube Research & Technologies (QRT) sold 933 Pliant Therapeutics shares in Q2 2026, an estimated $1.14K.
Pliant Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3274 holding.
Qube Research & Technologies (QRT) first reported a position in Pliant Therapeutics in Q2 2022 and has held it in 10 quarters since.
Qube Research & Technologies (QRT)'s Pliant Therapeutics position peaked at $4.68M in Q1 2023.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.